Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia

Objective: To evaluate the in vitro physicochemical stability of oxaliplatin anddoxorubicin when the in vivo hyperthermic intraperitoneal conditions arereproduced. Methods: Three solutions were prepared, A (oxaliplatin 200 mg/L), B(doxorubicin 15 mg/L) and C (oxaliplatin 200 mg/L with doxorubicin 1...

Full description

Saved in:
Bibliographic Details
Main Authors: V. Escudero-Ortiz, M.ª J. Duart-Duart, C. Pérez-Ruixo, J. J. Pérez-Ruixo, B. Valenzuela
Format: Article
Language:English
Published: Elsevier 2014-05-01
Series:Farmacia Hospitalaria
Subjects:
Online Access:http://www.aulamedica.es/fh/pdf/1170.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846093657628737536
author V. Escudero-Ortiz
M.ª J. Duart-Duart
C. Pérez-Ruixo
J. J. Pérez-Ruixo
B. Valenzuela
author_facet V. Escudero-Ortiz
M.ª J. Duart-Duart
C. Pérez-Ruixo
J. J. Pérez-Ruixo
B. Valenzuela
author_sort V. Escudero-Ortiz
collection DOAJ
description Objective: To evaluate the in vitro physicochemical stability of oxaliplatin anddoxorubicin when the in vivo hyperthermic intraperitoneal conditions arereproduced. Methods: Three solutions were prepared, A (oxaliplatin 200 mg/L), B(doxorubicin 15 mg/L) and C (oxaliplatin 200 mg/L with doxorubicin 15mg/L) in glucose 5%. The three solutions were subjected to the maximumtemperature reached in vivo (49° C) for two hours. Physical stability wasfocused on visual control of particles or precipitates in solutions, dischargeof gases, odor and color. Samples were taken every 15 minutes and thechemical stability was evaluated by determining the concentration of oxaliplatinand doxorubicin remaining in the samples. Oxaliplatin concentrationswere determined by atomic absorption graphite chamber whiledoxorubicin was determined by high performance liquid chromatography.The chemical stability criteria selected was the one described by the AmericanPharmacopoeia, which sets a permissible variation range betweenthe 90-110% of the initial concentration. Results: During the assay there was no appearance of particles, precipitatesin the samples, discharge of gases, nor colour changes in the solutions. Thesamples showed a remaining concentration of oxaliplatin and doxorubicinwithin the 90-110% limit. The stability of the samples that follow to twocycles of freeze-thaw after hyperthermia was also found within the specifiedlimits. Conclusion: A, B and c solutions in 5% glucose, are physically and chemicallystable at 49° C for two hours. Under these conditions, these solutionscould be used with guarantees of stability in patients with peritoneal carcinomatosissubsidiary of intraperitoneal hyperthermic chemotherapybased in these antineoplastic agents.
format Article
id doaj-art-9ed8b5ba81b34a2689ca2c06dd97147d
institution Kabale University
issn 1130-6343
2171-8695
language English
publishDate 2014-05-01
publisher Elsevier
record_format Article
series Farmacia Hospitalaria
spelling doaj-art-9ed8b5ba81b34a2689ca2c06dd97147d2025-01-02T16:48:24ZengElsevierFarmacia Hospitalaria1130-63432171-86952014-05-0138315416110.7399/fh.2014.38.3.1170Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermiaV. Escudero-Ortiz0M.ª J. Duart-Duart1C. Pérez-Ruixo2J. J. Pérez-Ruixo3B. Valenzuela4Plataforma de Oncología. Hospital Quirón. Torrevieja. AlicanteProfesora del Área de Farmacia y Tecnología Farmacéutica. Departamento de Ingeniería. Universidad Miguel Hernández. Alicante.Departamento de Farmacia y Tecnología Farmacéutica. Universidad de Valencia. Valencia. Consulting Projects for Research. ValenciaDirector Científico. Translational Sciences. AMGEN, Inc. España.Plataforma de Oncología. Hospital Quirón. Torrevieja. AlicanteObjective: To evaluate the in vitro physicochemical stability of oxaliplatin anddoxorubicin when the in vivo hyperthermic intraperitoneal conditions arereproduced. Methods: Three solutions were prepared, A (oxaliplatin 200 mg/L), B(doxorubicin 15 mg/L) and C (oxaliplatin 200 mg/L with doxorubicin 15mg/L) in glucose 5%. The three solutions were subjected to the maximumtemperature reached in vivo (49° C) for two hours. Physical stability wasfocused on visual control of particles or precipitates in solutions, dischargeof gases, odor and color. Samples were taken every 15 minutes and thechemical stability was evaluated by determining the concentration of oxaliplatinand doxorubicin remaining in the samples. Oxaliplatin concentrationswere determined by atomic absorption graphite chamber whiledoxorubicin was determined by high performance liquid chromatography.The chemical stability criteria selected was the one described by the AmericanPharmacopoeia, which sets a permissible variation range betweenthe 90-110% of the initial concentration. Results: During the assay there was no appearance of particles, precipitatesin the samples, discharge of gases, nor colour changes in the solutions. Thesamples showed a remaining concentration of oxaliplatin and doxorubicinwithin the 90-110% limit. The stability of the samples that follow to twocycles of freeze-thaw after hyperthermia was also found within the specifiedlimits. Conclusion: A, B and c solutions in 5% glucose, are physically and chemicallystable at 49° C for two hours. Under these conditions, these solutionscould be used with guarantees of stability in patients with peritoneal carcinomatosissubsidiary of intraperitoneal hyperthermic chemotherapybased in these antineoplastic agents.http://www.aulamedica.es/fh/pdf/1170.pdfOxaliplatin; DoxorubicinPeritoneal carcinomatosisHyperthermiaStability
spellingShingle V. Escudero-Ortiz
M.ª J. Duart-Duart
C. Pérez-Ruixo
J. J. Pérez-Ruixo
B. Valenzuela
Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
Farmacia Hospitalaria
Oxaliplatin
; Doxorubicin
Peritoneal carcinomatosis
Hyperthermia
Stability
title Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
title_full Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
title_fullStr Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
title_full_unstemmed Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
title_short Stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
title_sort stability study of oxaliplatin and doxorubicin for intraperitoneal administration with hyperthermia
topic Oxaliplatin
; Doxorubicin
Peritoneal carcinomatosis
Hyperthermia
Stability
url http://www.aulamedica.es/fh/pdf/1170.pdf
work_keys_str_mv AT vescuderoortiz stabilitystudyofoxaliplatinanddoxorubicinforintraperitonealadministrationwithhyperthermia
AT majduartduart stabilitystudyofoxaliplatinanddoxorubicinforintraperitonealadministrationwithhyperthermia
AT cperezruixo stabilitystudyofoxaliplatinanddoxorubicinforintraperitonealadministrationwithhyperthermia
AT jjperezruixo stabilitystudyofoxaliplatinanddoxorubicinforintraperitonealadministrationwithhyperthermia
AT bvalenzuela stabilitystudyofoxaliplatinanddoxorubicinforintraperitonealadministrationwithhyperthermia